D1 Capital Partners
Investment firm founded by Dan Sundheim (former Viking Global Investors CIO), managing both public and private equity. Known for concentrated positions in high-growth technology and healthcare companies.
Website
https://www.d1cap.comLocation
New York, USA
Founded
2018
AUM
$20B+
Investment Range
$50M - $500M
Portfolio Companies
1
Focus
generalist
Fund Stages
series-c, growth
Investment Thesis
D1 Capital Partners takes concentrated positions in exceptional companies across public and private markets, with significant exposure to technology and healthcare. They focus on companies with durable competitive advantages and long runways for growth, including genomics and life science tools companies.
Team
Partners / Managing Directors (Health & Bio Focus)
- Dan Sundheim - Founder & Chief Investment Officer
Other Key Team Members
- Investment team with hedge fund and private equity background
Focus Areas
- Technology
- Healthcare
- Genomics
- Consumer
- Public Equities
- Growth Equity
- Life Science Tools
Notable Exits
- Long-term holder with focus on growth
- Public and private market positions
Portfolio Companies (Healthcare/Biotech)
- Ultima Genomics ($600M funding round, 2022)
- Significant positions in public biotech companies
Sources
- https://www.d1cap.com
- https://www.d1cap.com/team
- SEC 13F filings
- Private placement reports
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Ultima Genomics | Fremont, California, USA | 2016 | genomics-sequencingbiotech+1 |